Epidemiology Outcomes
Michael Matthay (he/him/his)
California
Disclosure(s): Aerogen: Advisory Board (Ongoing); Calcimedica: Advisory Board (Ongoing); California Institute of Regeneration: Grant/Research Support (Ongoing); CSL Behring: Advisory Board (Ongoing); Gen1e Life Sciences: Advisory Board (Ongoing); Healios: Advisory Board (Ongoing); Merck: Advisory Board (Ongoing); NIH: Grant/Research Support (Ongoing); Novartis: Advisory Board (Ongoing); Quantum Leap Healthcare Collaborative: Grant/Research Support (Ongoing); RocheGenentech: Contracted Research (Terminated, December 31, 2025)